Robert A. Copeland
2012
In 2012, Robert A. Copeland earned a total compensation of $550.7K as Executive Vice President and Chief Scientific Officer at Epizyme.
Compensation breakdown
| Bonus | $125,903 |
|---|---|
| Option Awards | $92,813 |
| Salary | $314,757 |
| Other | $17,229 |
| Total | $550,702 |
Copeland received $314.8K in salary, accounting for 57% of the total pay in 2012.
Copeland also received $125.9K in bonus, $92.8K in option awards and $17.2K in other compensation.
Rankings
In 2012, Robert A. Copeland's compensation ranked 8,435th out of 11,487 executives tracked by ExecPay. In other words, Copeland earned more than 26.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,435 out of 11,487 | 27th |
Division Manufacturing | 3,062 out of 4,253 | 28th |
Major group Chemicals And Allied Products | 814 out of 1,203 | 32nd |
Industry group Drugs | 589 out of 925 | 36th |
Industry Pharmaceutical Preparations | 459 out of 700 | 34th |
Source: SEC filing on April 30, 2014.
Copeland's colleagues
We found three more compensation records of executives who worked with Robert A. Copeland at Epizyme in 2012.